{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:34:49Z","timestamp":1762324489830,"version":"3.30.1"},"reference-count":29,"publisher":"Medknow","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.sjopt.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T01:00:31Z","timestamp":1558141231000},"page":"117-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East"],"prefix":"10.4103","volume":"33","author":[{"given":"Sandra Flavia","family":"Fiorentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darakhshanda","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1016\/j.sjopt.2019.04.001_b0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eye drops in vernal keratoconjunctivitis","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0010","first-page":"25","article-title":"Vernal keratoconjunctivitis in Thailand","volume":"21","author":"Kosrirukvongs","year":"2003","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09286580802573177","article-title":"Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glipmse of ocular surface in Italian population","volume":"16","author":"Lambiase","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"issue":"1 Part 1","key":"10.1016\/j.sjopt.2019.04.001_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-6749(05)80033-8","article-title":"Allergic and immunologic disorders of the eye","volume":"89","author":"Bielory","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pai.12360","article-title":"Tacrolimus vs. Cyclosporine eye drops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blinded, crossover study","volume":"26","author":"Pucci","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0030","series-title":"Immunopathogenesis of ocular allergy. Progress in allergy and clinical immunology","first-page":"381","author":"Tabbara","year":"1997"},{"key":"10.1016\/j.sjopt.2019.04.001_b0035","first-page":"157","article-title":"Limbal vernal kerato- conjunctivitis in Yaounde, Cameroon. A clinico-immunology study","volume":"68","author":"McMoli","year":"1991","journal-title":"Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique"},{"key":"10.1016\/j.sjopt.2019.04.001_b0040","first-page":"71","article-title":"La limbo-conjunctivite endemique des tropiques","volume":"3\u20134","author":"Diallo","year":"1976","journal-title":"Rev Int Trachome"},{"key":"10.1016\/j.sjopt.2019.04.001_b0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1590\/S0004-27492005000500004","article-title":"Topographic corneal changes in patients with vernal conjunctivitis","volume":"68","author":"Dantas","year":"2005","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00417-007-0697-z","article-title":"Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy","author":"Uchio","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2007.06.028","article-title":"Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire","volume":"144","author":"Sacchetti","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: Pathogenesis and treatment","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.sjopt.2019.04.001_b0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00130832-200410000-00020","article-title":"Ocular allergic disease","volume":"4","author":"Stahl","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjuctivitis revisited: a case series of 195 patients with long-term follow up","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.sjopt.2019.04.001_b0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2006.01153.x","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL consensus report","volume":"61","author":"Akdnis","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.sjopt.2019.04.001_b0080","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1567-5769(01)00059-5","article-title":"Tacrolimus suppressed the production of cytokines involved in atopic dermatites by direct stimulation of human PBMC system. (Comparison with steroids)","volume":"1","author":"Sakuma","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.sjopt.2019.04.001_b0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-2001-18665","article-title":"FK 506 ointment 0.1% A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients","volume":"218","author":"Mayer","year":"2001","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.sjopt.2019.04.001_b0095","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/bjo.2009.172387","article-title":"Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis \u2013 case series","volume":"94","author":"Tam","year":"2010","journal-title":"Br J Ophthalmolol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0100","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","article-title":"Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkhah","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.sjopt.2019.04.001_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.sjopt.2019.04.001_b0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","article-title":"Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases","volume":"115","author":"Miyazaki","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.sjopt.2019.04.001_b0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.ico.0000240091.11854.14","article-title":"Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis","volume":"25","author":"Stumpf","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.sjopt.2019.04.001_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/ojo.OJO_232_2014","article-title":"Long-term use of 0.003% Tacrolimus suspension for treatment of vernal keratoconjunctivitis","volume":"10","author":"Al-Amri","year":"2017","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.sjopt.2019.04.001_b0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.sjopt.2019.04.001_b0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11882-013-0345-0","article-title":"Use of Cyclosporine A and Tacrolimus in treatment of vernal keratoconjunctivitis","volume":"13","author":"Vichyanond","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10.1016\/j.sjopt.2019.04.001_b0135","first-page":"1","article-title":"Therapeutic advances in cutaneous T-cell lymphoma","volume":"16","author":"Akilov","year":"2011","journal-title":"Skin Theraphy Lett"},{"issue":"4","key":"10.1016\/j.sjopt.2019.04.001_b0140","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.6173","article-title":"Topical calcineurin inhibitors and malignancy risk","volume":"10","author":"Radovic","year":"2017","journal-title":"Int J Cancer Manage"},{"key":"10.1016\/j.sjopt.2019.04.001_b0145","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1345\/aph.1M278","article-title":"Association between exposure to topical tacrolimus or pimecrolimus and cancers","volume":"43","author":"Hui","year":"2009","journal-title":"Ann Pharmacother"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453418301747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453418301747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T14:50:03Z","timestamp":1597935003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319453418301747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1319453418301747"],"URL":"https:\/\/doi.org\/10.1016\/j.sjopt.2019.04.001","relation":{},"ISSN":["1319-4534"],"issn-type":[{"type":"print","value":"1319-4534"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjopt.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Saudi Ophthalmological Society, King Saud University.","name":"copyright","label":"Copyright"}]}}